This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business shareholder investigation

Grabar Law Office Investigates Multiple Companies

Analysis based on 50 articles · First reported Oct 31, 2025 · Last updated Dec 09, 2025

Sentiment
-20
Attention
2
Articles
50
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The ongoing shareholder investigations by Meitar Law Offices into multiple publicly traded companies like Avantor, enCore Energy, Fortrea, Stride, Inc., Cytokinetics, Ibotta, Ivy Entertainment, Molina Healthcare, Synopsys, Humana, and Starbucks indicate potential financial liabilities and reputational damage for these entities. This could lead to decreased investor confidence, stock price volatility, and increased scrutiny on corporate governance and financial reporting across various industries.

Healthcare Technology Retail

Meitar Law Offices is actively investigating multiple publicly traded companies for alleged breaches of fiduciary duties and securities fraud. These investigations stem from underlying class action complaints alleging that companies such as Avantor, enCore Energy, Fortrea, Stride, Inc., Cytokinetics, Ibotta, Ivy Entertainment, Molina Healthcare, Synopsys, Humana, and Starbucks made materially false and misleading statements or failed to disclose crucial information to investors. The allegations range from misrepresenting competitive positioning and financial controls to inflating revenue targets, concealing declining user metrics, and downplaying medical cost pressures. Several of these class actions, including those against Ivy Entertainment, Starbucks, and Five Below, have survived motions to dismiss, indicating the courts found plausible grounds for the claims. Joshua H. Grabar is encouraging long-term shareholders to seek corporate reforms and the return of funds to the companies.

per
Joshua H. Grabar, representing Meitar Law Offices, is leading the investigations and encouraging shareholders to seek corporate reforms and return of funds to the companies.
Importance 80.0 Sentiment 10.0
priv
Meitar Law Offices is investigating multiple publicly traded companies for alleged breaches of fiduciary duties and securities fraud, representing shareholders in class action lawsuits.
Importance 80.0 Sentiment 10.0
stock
Synopsys is under investigation by Meitar Law Offices for allegedly artificially inflating its historical revenue and profit growth through unsustainable business practices, leading to a significant stock price plunge after Q3 2025 results.
Importance 80.0 Sentiment -50.0
stock
Cytokinetics is under investigation by Meitar Law Offices for allegedly making false and misleading statements regarding its New Drug Application for aficamten, specifically failing to include a Risk Evaluation and Mitigation Strategy (REMS) in its initial NDA.
Importance 75.0 Sentiment -40.0
priv
Ivy Entertainment is under investigation by Meitar Law Offices after a class action lawsuit survived a motion to dismiss, alleging the company misled investors about declining Monthly Active Users (MAU) and foreign currency fluctuations prior to its IPO.
Importance 75.0 Sentiment -35.0
stock
enCore Energy is being investigated by Meitar Law Offices for allegedly lacking effective internal controls over financial reporting and misrepresenting its business operations, resulting in increased net losses.
Importance 70.0 Sentiment -30.0
stock
Avantor is under investigation by Meitar Law Offices for allegedly making false and misleading statements about its competitive positioning and negative effects from increased competition, leading to a securities fraud class action.
Importance 70.0 Sentiment -30.0
stock
Stride, Inc. is being investigated by Meitar Law Offices for allegedly inflating enrollment numbers, cutting staffing costs, ignoring compliance requirements, and suppressing whistleblowers.
Importance 70.0 Sentiment -30.0
stock
Molina Healthcare is being investigated by Meitar Law Offices for allegedly failing to disclose material adverse facts concerning its medical cost trend assumptions and the dislocation between premium rates and medical cost trends.
Importance 70.0 Sentiment -30.0
stock
Fortrea is under investigation by Meitar Law Offices for allegedly making false and misleading statements regarding its revenue contributions from Pre-Spin Projects and overstated cost savings, inflating its 2025 EBITDA targets.
Importance 70.0 Sentiment -30.0
priv
Ibotta is being investigated by Meitar Law Offices for allegedly failing to warn investors about the at-will nature of its contract with Kroger in its IPO Registration Statement.
Importance 65.0 Sentiment -30.0
stock
Five Below is being investigated by Meitar Law Offices after a class action lawsuit survived a motion to dismiss, alleging the company provided misleading information about its financial strength and operations, including issues with its trend-right strategy and inventory.
Importance 60.0 Sentiment -25.0
stock
Humana is being investigated by Meitar Law Offices for allegedly downplaying pressures on its adjusted EPS due to increased medical costs and utilization rates.
Importance 60.0 Sentiment -30.0
stock
Starbucks is under investigation by Meitar Law Offices after a class action lawsuit survived a motion to dismiss, alleging the company hid declining store traffic in the United States and China.
Importance 60.0 Sentiment -25.0
per
Robert I. Blum, CEO of Cytokinetics, acknowledged the company's decision to submit the NDA for aficamten without a REMS despite prior discussions with the FDA, contributing to the shareholder investigation.
Importance 50.0 Sentiment -40.0
+ 4 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.